OTC · Financial Statements

Cannabis Strategic Ventures (NUGS) Financial Statements

$0.01 OTC: NUGS Market Cap $2.25M

Cannabis Strategic Ventures most recently reported annual revenue of $10.0M, net profit of $-9.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20172018201920202021
Revenue$0$1.0M$2.0M$15.0M$10.0M
Operating Profit$-4.0M$-21.0M$-9.0M$-5.0M$-7.0M
Net Profit$-8.0M$-21.0M$-9.0M$-6.0M$-9.0M
EPS$0.00$-0.08$-0.04$-0.02$-0.03
Op Margin-1291.0%-3008.1%-362.4%-36.3%-73.3%

Balance Sheet (USD)

Metric20172018201920202021
Total Assets$12.0M$3.0M$18.0M$16.0M$11.0M
Total Liabilities$2.0M$2.0M$24.0M$24.0M$20.0M
Cash$0$0$0$0$0
Borrowings$0$1.0M$21.0M$22.0M$14.0M

Cash Flow (USD)

Metric20172018201920202021
Operating Cash Flow$-1.0M$-3.0M$-8.0M$-4.0M$-1.0M
Investing Cash Flow$0$0$-7.0M$-2.0M$0
Financing Cash Flow$0$2.0M$0$0$0
Net Cash Flow$0$0$0$0$0
Free Cash Flow$-1.0M$-3.0M$-11.0M$-5.0M$-1.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-2.82
FCF Yield-63.43%
Quick Ratio0.02
Interest Coverage-5.32
Return 1Y6000.00%
Return 3Y38.64%
Return 5Y-86.93%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
NUGS Overview NUGS Dividend Run Stock Screener